Paying for testing
Oncotype DX cost and availability in India
A genomic recurrence test is one of the more expensive single tests in breast cancer care, and most schemes and insurance policies do not cover it. It is usually paid out of pocket. This page sets out indicative ranges, explains what the quote should include, and gives you the questions that decide whether the test is worth paying for at all.
The short answer
What does a genomic recurrence test cost in India?
A genomic recurrence test is one of the more expensive single tests in breast cancer care, and most schemes and policies do not cover it. It is usually paid for out of pocket, and the price is quoted per test with the shipping and handling included.
Why it costs what it does
The test is run in a small number of laboratories, mostly outside India, under a patented method. Your tissue block has to be prepared, shipped and returned, and the paperwork handled. There is no generic version, because the value is in the validated formula rather than in the chemicals.
Why the decision is still worth making carefully
Set the cost against what it can save you. A course of chemotherapy carries its own bills, its own weeks away from work and its own effects on your body. Where the test genuinely prevents unnecessary chemotherapy, many families find it pays for itself.
Where your oncologist already knows the answer, the test changes nothing and the money is better kept.Indicative cost
What families typically spend
These are ranges, not quotes. Ask your hospital for the current figure in writing before you agree to anything.
Oncotype DX
The most widely used test, shipped abroad. Usually quoted as a single all-inclusive figure.
Other international panels
MammaPrint, Prosigna and EndoPredict sit in a broadly similar range, with the exact figure depending on the laboratory.
India-developed alternatives
Locally developed tests are considerably cheaper. Ask how well validated the one being offered is before choosing on price.
Indicative only, and prices move. Aarogyasri, CGHS, ECHS and EHS generally do not cover genomic recurrence testing, and most cashless insurers treat it as an investigation rather than a covered procedure, so it is usually paid out of pocket. Prices vary between laboratories, cities and hospitals, so compare more than one. Ask for a written quote and check your own policy wording before agreeing. Call the helpline if you want the current figure checked against your cover.
Before you pay
Four questions worth asking first
The answers decide whether this is money well spent or money spent on a result nobody will act on.
Would a low result change your advice?
This is the question that settles it. If your oncologist would recommend chemotherapy regardless, or would leave it out regardless, the test is not worth paying for.
Am I in the group it was designed for?
These tests apply to hormone sensitive, HER2 negative cancers. In HER2 positive or triple negative disease they have no role, and any offer to run one should be questioned.
Check your own receptor results first.What exactly is included in the quote?
Ask whether shipping, handling, the hospital's own charge and taxes are all inside the figure. Families are often quoted the laboratory price and then billed for the rest.
What does delay cost me?
Waiting for a result pushes back the start of treatment by a few weeks. Usually that is acceptable. Ask directly whether it is in your case.
Get in writing
- The all-inclusive price
- The expected date of the result
- Who to contact if it is late
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Who pays
What each scheme generally does
Being straight with you
What this page cannot tell you
It cannot give you a quote. Prices differ between hospitals, move with the exchange rate and change when laboratories revise their charges. Any figure you read online, here included, is a starting point for a conversation and nothing more.
Cheaper is not automatically worse, or better
India-developed tests cost considerably less and some have been through proper validation. Others have less published evidence behind them. Ask specifically what studies support the test being offered and whether your oncologist would act on its result. A cheap test nobody trusts is more expensive than no test at all.
There is no EMI offer
Be careful of anyone presenting a payment plan as though it came from us. CION does not offer instalment schemes for tests or treatment. If affording this is the obstacle, say so plainly to your oncologist, because there are usually other ways through the decision.
Compare written quotes
Prices differ between laboratories, cities and hospitals, so it is worth comparing more than one written quote before you decide.
What to do next
Ask for a written quote, ask whether the result would change the recommendation, and ask your insurer in writing before you pay. Those three steps take a day and routinely save families a great deal of money.
Commonly believed
What families believe about paying for this test
Price reflects where the test is run and what it is patented under, not how well it answers your question. What matters is whether the test has been validated in women like you and whether your oncologist would act on the result. Ask those two things before comparing prices.
Paying for the test buys a number, not an outcome. The result may well come back recommending chemotherapy. Families who take out loans expecting the test to rule it out are often left worse off in both directions.
Most policies treat it as an investigation and exclude it, and claims made after the fact on an excluded item are usually refused. Get your insurer's position in writing before the tissue is sent, not after the invoice arrives.
Some locally developed tests have been through proper validation and are used routinely by oncologists here. Others have far less evidence behind them. The question is not where the test was developed but what studies stand behind the one you are being offered.
Questions we are asked
Common questions about the cost
Is the test covered by Aarogyasri?
Generally no. The scheme's packages are built around treatment rather than this kind of investigation. Ask your hospital's scheme desk to confirm in writing for your own case, because package lists are revised from time to time.
Why is it so expensive?
The test runs in a small number of laboratories under a patented method, and your tissue is usually shipped abroad and back. The cost is in the validated formula and the logistics rather than in the chemicals, so there is no cheaper version of the same test.
Are the Indian tests as good?
Some have been properly validated and are used by oncologists here. Others have less evidence behind them. Ask which test is being proposed, what studies support it, and whether your oncologist would act on a low result from it.
Can I claim it back afterwards?
Rarely, and trying is a poor plan. Get your insurer's position in writing before the test is sent, and keep the prescription, the invoice and the report. Claims submitted afterwards on an excluded item are usually refused.
Is it cheaper if I arrange it myself?
Usually not, and it creates problems. The tissue block has to be released by the laboratory that holds it and shipped correctly. Let your hospital handle it, but ask them to itemise their own handling charge in the quote.
What if I cannot afford it?
Say so directly to your oncologist. They can tell you whether the decision can be made without it, whether a cheaper validated test is reasonable in your case, or whether any assistance programme is currently open. This is a common conversation and not an awkward one.
Does the price include everything?
Not always. Ask whether shipping, handling, the hospital's charge and taxes are inside the figure you have been given. Families are frequently quoted the laboratory price alone and then billed for the rest afterwards.
Will the price change if I wait?
It can, as these tests are priced partly in foreign currency. That is not a reason to rush the decision. A few days spent getting a written quote and checking your policy is time well spent.
What moves the figure
What affects the cost
Four things change the total more than anything else.
The technique used
A shaped or image-guided delivery costs more than a conventional one, and is chosen on clinical grounds rather than preference.
How many sessions
The total is driven by the number of sittings or cycles, not by a single per-visit figure.
Supporting tests
Scans, blood work and pathology done alongside treatment are billed separately.
Your cover
Aarogyasri, CGHS, ECHS, EHS or cashless insurance usually change the out-of-pocket figure substantially.
Paying for it
Insurance, schemes and payment
What you actually pay usually differs a great deal from the sticker figure.
Accreditation and empanelment
- NABH
- NABL
- ISO 9001:2015
- ArogyaSri empanelled
- CGHS accepted
- ECHS accepted
- EHS accepted
- Major cashless insurers
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Sources
- National Cancer Institute — Breast cancer gene expression tests
- Aarogyasri Health Care Trust, Government of Telangana — Aarogyasri Scheme
- Insurance Regulatory and Development Authority of India — IRDAI: protecting the interests of policyholders
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.